Medicine
Mefloquine 250 mg tablet
Mefloquine 250 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°-25°C (68°-77°F).
Key facts
- Active ingredient (INN)
- Mefloquine
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 5 tablets, 25 tablets, 25 blister pack and 1 more
- Manufacturers
- Chartwell RXA-S Medication SolutionsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°-25°C (68°-77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- P01BC02 Mefloquine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 January 2004
- Identifiers
- RxCUI 835913DailyMed set ID b884d22b-aae7-4f14-9a04-ae4029a229f0, 09716a24-d7da-42b2-af29-c03a1b6670bd, 9cbe26c7-7313-4cd6-9514-9190af1de763NDC 62135-973, 0555-0171, 50090-2396Application ANDA076175, ANDA076392
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 tablet in 1 bottle | 62135-973-11 | Chartwell RX | 15 November 2024 |
| 25 tablet in 1 bottle | 62135-973-25 | Chartwell RX | 15 November 2024 |
| 25 blister pack in 1 carton / 1 tablet in 1 blister pack | 0555-0171-78 | Teva Pharmaceuticals | 6 January 2004 |
| 1 blister pack in 1 carton / 10 tablet in 1 blister pack | 50090-2396-0 | A-S Medication Solutions | 6 May 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 May 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Mefloquine is an antimalarial indicated for the treatment of mild to moderate acute malaria caused by mefloquine-susceptible strains of P. falciparum (both chloroquine-susceptible and resistant strains) or by Plasmodium vivax. MedsAcross supplies Mefloquine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MefloquineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mefloquine Hydrochloride prescribing information (Teva Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Mefloquine 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.